Since POM121 is frequently overexpressed in cancers including CRC, this post-translational inhibition of PPARγ may prevent its anti-proliferative, differentiation-promoting effects in tumor cells and also mitigate its modulatory function on metabolism and immunity. Here, PPARG is linked to cancer.